Pioneering cellular medicines for women’s health
We’re developing off-the-shelf cell therapies for high-impact women’s diseases, with lead programs in ovarian cancer, triple negative breast cancer and endometriosis.
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.
Some of our partners
Latest news
Good News from Cartherics
By Christine Filippis / August 19, 2020
New funding from the Federal Entrepreneurs Programme will boost the company’s R&D efforts By Leigh Dayton “It’s good to get...
Read More
Cartherics attends international meeting of cell therapy leaders – virtually.
By Christine Filippis / July 8, 2020
Join a panel on “off-the-shelf” therapies with CEO Alan Trounson By Leigh Dayton 8 July 2020 Cartherics will take part...
Read More
What’s COVID-19 doing to Australian Biotech ?
By Christine Filippis / June 4, 2020
Cartherics Chief Scientific Officer Richard Boyd and Chief Operating Officer Ian Nisbet take a hard look It’s hardly news. COVID-19...
Read More
